Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Bimekizumab▼in Hidradenitis Suppurativa (HS)
14
Mins
January 2026
Experts explore 3-year clinical data on bimekizumab presented at the 2025 EADV and SHSA congresses, highlighting its durable and deep…
Read more
14
Mins
12 Sep 2024
Clinical Practice Insights for Hyperpigmentation Treatment
Hyperpigmentation disorders, a group of common skin conditions characterised by darkened patches due to excess melanin production, affect…
12
Mins
9 Aug 2024
Reviewing Non-Scarring Alopecia in Women
Scalp hair is often regarded as a symbol of beauty and vitality across many cultures. Consequently, the loss of hair can significantly…
9
Mins
13 Jun 2024
Dermatitis Artefacta Treatment
Dermatitis artefacta (DA), also known as artefactual skin disease, is a rare psychocutaneous disorder characterised by…
9
Mins
13 Jun 2024
Caregiver Burden, Resilience, and Wellbeing in Cases of SCAR
Severe cutaneous adverse drug reactions (SCAR) are a group of rare but potentially life-threatening conditions that can occur in response…
5 Jun 2024
JAK Inhibitors: A New Frontier in Dermatology
JAK INHIBITORS have changed dermatology, and will continue to change dermatology in ways that no other class of drugs has…
1
Mins
12 Feb 2024
Author Response to: Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’
The aim of our work was to underline that surgery can be applied as a first-line treatment. This was also the shared starting assumption…
15
Mins
30 Jan 2024
Exploring Advancements and Challenges in Adjuvant Melanoma Treatment
Melanoma of the skin is a common type of cancer that primarily affects younger patients. In Stage III melanoma, which does not involve…
1
Mins
25 Jan 2024
Letter To the Editor Concerning ‘Lichen Sclerosus in Prepubertal Males: Breaking the Paradigm’
We agree that the topic of treatment of penile lichen sclerosus in boys is important, and needs more attention in clinical research and…
7
Mins
23 Nov 2023
Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas
Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…
8
Mins
23 Nov 2023
Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity
Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
2
Mins
23 Nov 2023
Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo
Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
10
Mins
23 Nov 2023
A New Landmark for Wellbeing in Psoriasis: The POSITIVE Study
Psoriatic disease is a chronic, inflammatory immune condition affecting more than 40 million individuals worldwide…
13
Mins
17 Nov 2023
Platelet-Rich Plasma Applications, The Past 5 Years
This review article aims to provide an overview of platelet-rich plasma’s applications and evidence over the past 5 years in randomised…
9
Mins
26 Oct 2023
Editor's Pick: Diagnostic Evaluation of Hair Loss: A Narrative Review
This review provides a systematic approach for dermatologists to use in order to accurately diagnose hair loss disorders…
10
Mins
12 Oct 2023
Patient Centricity in Skin Treatments: Global Meeting of Experts in Dermatology
During this symposium, global experts in dermatology gave a series of lectures focused on skin treatments and their benefits for patients…
5
Mins
5 Oct 2023
Mycosis Fungoides Palmaris et Plantaris Progressing to Complete Early-Stage Disease Improved with Phototherapy
Mycosis fungoides is the most common form of cutaneous T cell lymphoma. In this article, the authors describe a case of a 53-year-old…
8
Mins
5 Sep 2023
Editor’s Pick: Assessing the Relationship Between Vitiligo and Cardiovascular Disease Risk Factors
Vitiligo is an autoimmune disorder characterised by the loss of melanocytes, resulting in white, depigmented cutaneous macules…
6
Mins
9 Aug 2023
Collagen-Filler Injection Associated Dermopathy and COVID-19
COVID-19 and cosmetic skin-fillers are two prevalent topics of today’s medicine, yet their interaction is not sufficiently studied. This…
5
Mins
8 Aug 2023
Systemic Sclerosis Manifesting Post-Radiotherapy: A Case Report
Morphoea causes skin and subcutaneous tissue fibrosis, and can sometimes involve the fascia, muscle, or bone. Sclerosis usually begins as…
7
Mins
24 Jul 2023
Progressive Facial Hemiatrophy (Parry–Romberg Syndrome) Treated with Hyaluronic Acid Fillers
Parry–Romberg syndrome (PRS) is a rare neurocutaneous condition that can affect the skin, subcutaneous fat, muscle, and bone on one side…
11
Mins
15 Jun 2023
Elevating Aesthetics: Patient-Specific Treatment with Hyaluronic Acid Fillers to Improve Appearance and Psychosocial Wellbeing
This review of the ‘Elevating Aesthetics’ symposium held at the International Master Course on Aging Science (IMCAS) 2023 shares insights…
3
Mins
31 May 2023
Interview: Edel O’Toole
I was always interested in biology and science. As a child, I loved identifying wild flowers and this is not all that dissimilar to…
7
Mins
23 May 2023
Interview: Christopher Griffiths
There were actually two reasons. When I was about 4 years old, I was given a bird book by my parents and I memorised every bird…
3
Mins
16 May 2023
Cutaneous Squamous Cell Carcinoma of the Hand Presenting as Clinical Perineural Invasion
Cutaneous squamous cell carcinoma (SCC) contributes to 20% of non-melanoma skin cancers and early diagnosis is vital to reducing…
11
Mins
12 Apr 2023
IL-17 and -23 Inhibitors for the Treatment of Psoriasis
Psoriasis is a chronic inflammatory skin disorder affecting approximately 60 million people worldwide. The condition presents with rapid hyperproliferation and dysregulated differentiation of epidermal keratinocytes, manifesting clinically as salmon pink plaques with overlying silvery-white scale.
25 Nov 2022
Clinical Efficacy and Outcomes of Remibrutinib (LOU064) in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1-Antihistamines: Findings from a Phase IIb Study
As part of the 31st European Academy of Dermatology and Venereology (EADV) Annual Congress held in Milan, Italy, and online, 7th–10th September 2022, five poster presentations outlined results from the Phase IIb study of remibrutinib (LOU064) in patients with chronic spontaneous urticaria inadequately controlled with H1-antihistamines.
11
Mins
14 Nov 2022
An Overview of the EORTC-CLTG 2022 Congress
This year’s European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Tumours Group (CLTG) Annual Meeting was held in Madrid, Spain. Presentations covered a broad range of topics in the field of cutaneous lymphomas, from molecular mechanisms, through diagnostics and prediction of prognosis, to skin-directed and targeted therapies, combination therapies, and patient-reported outcomes.
6
Mins
20 Oct 2022
Photoprotection and the Science Behind Skin Healing
Sun exposure can lead to tanning, but also to skin damage due to the actions of ultraviolet A and B, visible light, and infrared radiation. One result of sun exposure is field cancerisation (FC), the precursor to actinic keratosis (AK), which in turn is a risk factor for, most notably, squamous cell carcinoma.
6
Mins
20 Oct 2022
Clinical Efficacy and Outcomes of Remibrutinib (LOU064) in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1-Antihistamines: Findings from a Phase IIb Study
Chronic spontaneous urticaria (CSU) is characterised by the spontaneous occurrence of wheals (hives) and/or angioedema for ≥6 weeks.1 CSU can persist for several years and is associated with severe pruritus. Skin mast cell activation in CSU occurs via Type I autoallergy driven by IgE to autoallergens, and a Type IIb autoimmune response due to mast cell-targeted autoantibodies against IgE or high-affinity IgE receptor.
5
Mins
20 Oct 2022
Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: Primary Endpoint Analysis from the SUNSHINE and SUNRISE Phase III Trials
The primary endpoint analyses from the SUNSHINE and SUNRISE Phase III trials of secukinumab in moderate-to-severe hidradenitis suppurativa (HS) were featured in an oral presentation as part of the late-breaking news session at the 31st annual European Academy of Dermatology and Venereology (EADV) congress. Known collectively as the SUNNY trials, the SUNSHINE and SUNRISE studies represent the largest Phase III trials conducted in HS to date.
5
Mins
4 Jul 2022
Editor's Pick: Pemphigus Vulgaris and Pemphigus Foliaceus: A Single-Centre Comparative Study in Rabat, Morocco
Pemphigus is a group of rare autoimmune blistering diseases affecting the skin and mucous membranes. Pemphigus foliaceus (PF)…
9
Mins
16 Jun 2022
Beyond Aesthetics: Hyaluronic Acid Fillers as a Therapeutic Treatment
Any filler injection requires a bespoke treatment approach and a thorough anatomy knowledge to minimise procedural risks and achieve…
10
Mins
30 May 2022
A Retrospective Database Cohort Study Evaluating the Association Between Immune Suppressive Therapy and the Development of Cancer in Patients with Atopic Dermatitis Within UK Primary Care
Atopic dermatitis (AD) is the most common inflammatory skin condition, affecting 11–20% of children and 5–10% of adults…
7
Mins
9 May 2022
Trichotillomania with Giant Gastric Trichobezoar in a Female Child: A Case Report
Trichotillomania is defined by the Diagnostics and Statistic Manual of Mental Disorders (DSM-5) as an individual repetitively pulling…
5
Mins
2 May 2022
Varicella Zoster Reactivation Following mRNA Vaccination: Two Case Reports and a Review of Cutaneous Adverse Events of COVID-19 Vaccines
Varicella Zoster reactivation and cutaneous reaction as a mRNA vaccine side effect following COVID 19 vaccination…
4
Mins
28 Apr 2022
Case Report of Epstein–Barr Virus-Induced Autoimmune Vitiligo in Nigeria
Vitiligo is an acquired skin depigmenting disorder resulting from melanocytes loss in the epidermis, associated with an autoimmune aetiopathophysiology. However, there are limited data about the association between vitiligo and Epstein–Barr virus (EBV).
5
Mins
11 Apr 2022
Severe Sunburn-Like Adverse Cutaneous Drug Reaction in a Patient on Treatment with Rifaximin: A Rare Case of Acute Phototoxic Drug Reaction
Drug-induced photosensitivity is an adverse cutaneous reaction caused by a simultaneous exposure to potentially photosensitising drugs (via topical application or parenteral administration) and ultraviolet (UV) radiation or visible light.
6
Mins
2 Mar 2022
Revolution in Photoprotection: How to Recommend and Adapt Photoprotection According to Skin Phototype and Dermatoses
The solar spectrum is composed of various wavelengths of electromagnetic radiation that can penetrate the skin to different levels: the longer…
4
Mins
21 Feb 2022
Paget Disease of Skin Secondary to Urothelial Carcinoma
Currently, the exact mechanism underlying EMPD is unknown, but two widely known theories exist, namely the epidermotropic and transformation theories.
5
Mins
21 Feb 2022
Treatment with Hyaluronic Acid Injections in a Patient with Craniosynostosis
A case of a 25-year-old White female left with residual bone deformity after surgical correction of craniosynostosis during childhood…
5
Mins
3 Feb 2022
Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from the EADV 2021
The latest research on autoimmune skin disease has studied the efficacy and safety characterisation of guselkumab (GUS), a human monoclonal…
10
Mins
3 Feb 2022
Diving Deep: Harnessing the Potential of the IL-23 Pathway
Strober began by summarising his opinion on the key characteristics of anti-IL-23 therapies that support their efficacy for inducing…
6
Mins
17 Jan 2022
Dermatophyte Monitoring in an Iranian Training Dermatology Hospital
Dermatophytes are the keratinophilic moulds living on the superficial layer of human and animal skin and are transmitted by direct and…
4
Mins
11 Nov 2021
Eleven Myths on Nail Melanoma
A number of misconceptions prevail in nail melanoma. This short essay tries to clarify some of these issues.
4
Mins
11 Nov 2021
Interview: Peter Lio
Interviewing Peter Lio, Clinical Assistant Professor of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine
8
Mins
11 Nov 2021
The Benefits of Achieving Complete Control in Patients with Chronic Spontaneous Urticaria
The latest international guidelines on urticaria were published in September as a joint initiative from the European Academy of…
10
Mins
11 Nov 2021
Tailored Injection Techniques in the Mid- and Lower Face Using a Multilayering Approach
Recent years have witnessed significant advances in the understanding of facial anatomy. Extensive studies have uncovered the arrangement of soft-tissue layers underlying the skin and their mobility during expression. Meanwhile, increasing awareness of the facial vascular network has laid the foundation for lower risk cosmetic procedures.
3
Mins
11 Nov 2021
Interview: Roxana Daneshjou
An interview with Roxana Daneshjou, Clinical Scholar of Dermatology, Stanford University, California, USA.
7
Mins
11 Nov 2021
Mosaicism in Tuberous Sclerosis Complex: A Case Report, Literature Review, and Original Data from Danish Hospitals
Tuberous sclerosis complex (TSC) is an autosomal dominant hereditary disease with hamartomatous growths in multiple organs due to…
9
Mins
11 Nov 2021
Emerging Treatment Regimens in Psoriasis: Are There Advantages Over Current Biologic Therapies?
Psoriasis is a chronic inflammatory skin condition that impacts patients’ quality of life and has large economic consequences…
10
Mins
22 Oct 2021
Patient-Reported Outcomes with Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis
Richard B. Warren highlighted Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the Phase III BE VIVID trial in patients…
10
Mins
20 Oct 2021
Efficacy and Safety of Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis
In the late-breaking research sessions, Reich presented BE RADIANT, the first Phase III trial to compare inhibition of IL-17A and IL-17F…
6
Mins
15 Oct 2021
Where Do We Begin? The Key Role of the IL-23 Pathway in Psoriasis and Psoriatic Arthritis
This Janssen-sponsored live satellite symposium, entitled ‘Where do we begin? The key role of the IL-23 pathway in psoriasis and psoriatic…
9
Mins
17 Jun 2021
Pioneering Best Practices in Atopic Dermatitis: Results from the Quality of Care Initiative
Pioneering global best practices in atopic dermatitis (AD) and implementing them in the clinic are important steps towards optimising patient care…
11
Mins
17 May 2021
Botulinum Toxins in Medical and Cosmetic Dermatology
Botulinum neurotoxins (BoNTs) are derived from Clostridium botulinum, a gram-positive anaerobe. While there are seven subtypes of BoNT (A to G), only A…
5
Mins
3 May 2021
Prominent Cutaneous Manifestation of COVID-19: A Case Report
The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen and the subsequent coronavirus disease (COVID-19) mainly affect the lung…
10
Mins
29 Mar 2021
Advancing Breakthrough Innovative Treatment in Paediatric Dermatitis and Various Skin Disorders
Eczematous dermatitis (or eczema) includes AD, CD, and DD. This inflammatory skin reaction presents as erythema, vesicles, desquamation…
15
Mins
23 Mar 2021
The Treatment Landscape of Atopic Dermatitis: Interviews with Three Consultant Dermatologists
Atopic dermatitis (AD), sometimes referred to as ‘atopic eczema’, is a common, chronic, pruritic, Type II inflammatory skin disease which is associated…
12
Mins
23 Mar 2021
Transient Cutaneous Alterations of the Newborn
At birth, the skin of the newborn suddenly comes into contact with the extrauterine world: a dry and aerobic environment.1 Newborn skin is 40–60%…
14
Mins
15 Mar 2021
Syphilis Diagnosis and Treatment: State of The Art
Syphilis is a chronic bacterial infection caused by Treponema pallidum subspecies pallidum, known by clinicians for hundreds of years and with more than 5 million new cases diagnosed every year worldwide…
11
Mins
25 Feb 2021
Clinical Considerations Based On 5-Year Efficacy and Safety Data for the IL-23p19 Inhibitor Tildrakizumab
The indicative scaly, erythematous plaques of plaque psoriasis arise because of abnormal interactions between immune system cells and epidermal…
9
Mins
18 Feb 2021
Biological and Clinical Impacts of Ultraviolet-A on the Skin: New Insights
Terrestrial solar UVR consists of UVA (320–400 nm) and UVB (280–320 nm; typically around 295–320nm because of attenuation by the ozone…
11
Mins
10 Feb 2021
Long-term Efficacy and Safety of Tildrakizumab: 5-year Results from the reSURFACE 1 and 2 Phase III Trials in Patients with Moderate-to-severe Plaque Psoriasis
Psoriasis, a chronic systemic inflammatory disease with skin manifestations, can be an impediment to daily life. Accordingly…
8
Mins
15 Dec 2020
The Other Side of the Moon: A Clinical Dialogue on the IL-23 Pathway
Prof Reich began by highlighting how insights into the pathophysiology of psoriasis have led to the development and expansion of cytokine-targeted…
6
Mins
15 Dec 2020
Latest Highlights on Biologic Treatments for Psoriasis and Psoriatic Arthritis from EADV 2020
The VOYAGE 1 trial1 was a placebo- and active-controlled Phase III study to evaluate long-term efficacy and safety of the IL-23p19 inhibitor guselkumab…
8
Mins
15 Dec 2020
Bimekizumab Efficacy and Safety in Patients with Moderate-to-Severe Plaque Psoriasis
Psoriasis is a Th17-driven disease, with both IL-17A and IL-17F playing a pivotal role in its pathogenesis.2,3 BKZ is a monoclonal IgG1 antibody…
9
Mins
15 Dec 2020
Editor’s Pick: Managing Chronic Urticaria: Quo Vadis?
Chronic urticaria (CU) is one of the most commonly diagnosed skin conditions. CU is characterised by the presence of recurrent wheals and/or angioedema…
8
Mins
15 Dec 2020
Impaired Mitochondrial and Metabolic Function of Fibroblasts Derived from Patients with Recessive Dystrophic and Junctional Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosa (RDEB) and junctional EB (JEB) are inherited disorders characterised by fragility and blistering of epithelial…
11
Mins
15 Dec 2020
Management of Plaque Psoriasis: A Review and Comparison of IL-23 Inhibitors
With the recent advancements of biologic therapies that block IL-23, there is increasing need for analysis of which biologics are most efficacious…
4
Mins
15 Dec 2020
Case Report: Suspected Case of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Overlap Due to Ursodeoxycholic Acid
Stevens–Johnson syndrome and toxic epidermal necrolysis are well-known severe cutaneous adverse reactions, with >100 medications previously implicated…
8
Mins
17 Aug 2020
Differential Diagnosis of Nail Psoriasis and Onychomycoses: A Report Based on 40 Years of Specialised Nail Consultations
Ungual psoriasis and onychomycosis are common nail diseases. Despite their different aetiology and course, surprisingly they have much in common.
6
Mins
31 Jul 2020
Clinical Cases in Dermatology: Modern Management of Acne, Actinic Keratosis, and Atopic Dermatitis
This clinical dermatology report examines six short case studies of patients diagnosed with acne vulgaris, actinic keratosis (AK), and atopic dermatitis (AD)…
6
Mins
23 Jun 2020
Chlormethine Gel for Mycosis Fungoides T-cell Lymphoma: Recent Real-World Data
An enhanced understanding of real-world CL Gel usage could help improve the management of patients with MF-CTCL…
10
Mins
23 Jun 2020
Managing Pemphigoid Gestationis
Pemphigoid gestationis (PG) is a rare pruritic autoimmune blistering skin disease associated with pregnancy and is classified as a pregnancy-specific…
12
Mins
28 May 2020
Holistic Assessment is Vital: Key Considerations in the Treatment of the Psychosocial Elements of Psoriasis
“Psoriasis isn’t just a skin disease”: depression, anxiety, and alexithymia are common in people living with the condition, as are low self-esteem…
9
Mins
14 May 2020
Highlights of the European Organisation for Research and Treatment of Cancer-Cutaneous Lymphoma Task Force (EORTC-CLTF) Annual Congress 2019 (Athens, Sept 26-28): Experiences with Chlormethine Gel in Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)
MF-CTCL is a rare type of cutaneous non-Hodgkin’s lymphoma where uncontrolled growth of the pathological skin-homing T-lymphocytes results first in skin…
10
Mins
11 May 2020
Photoprotection: Key Concepts, Current Status, and Special Patient Groups
Cumulative or excessive solar exposure is detrimental to skin health.1 Furthermore, certain population groups require extra care…
4
Mins
4 May 2020
Sebaceous Carcinoma: A Rare Extraocular Presentation of the Cheek
Sebaceous carcinoma is a rare and very aggressive malignant skin cancer of the sebaceous gland. While sebaceous glands are present all over the body…
10
Mins
31 Mar 2020
Editor's Pick: Chronic Spontaneous Urticaria: A Review of Pathological Mechanisms, Diagnosis, Clinical Management, and Treatment
Urticaria is a common mast cell-driven disease characterised by wheals and/or angioedema (), defined as chronic…
6
Mins
31 Mar 2020
Clinical Profile of Patients with Psoriasis and their Attitude Towards the Illness
Skin diseases such as psoriasis can profoundly influence a patient’s self-image, self-esteem, and sense of wellbeing. The chronic nature of the disease…
9
Mins
28 Feb 2020
Biologics in Moderate-to-Severe Psoriasis: Discover the Road to Long-term Control
Advances in the treatment of moderate-to-severe psoriasis have accelerated considerably in the last 30 years. Prof Piaserico provided an overview of the…
8
Mins
28 Feb 2020
Tildrakizumab in Patients with Moderate-to-Severe Psoriasis: Post-Hoc Analyses on Efficacy, Time to Relapse, Long-Term Safety in Elderly Population and Predictability From The reSURFACE 1 and reSURFACE 2 Phase III Clinical Trials
Psoriasis is a chronic, relapsing inflammatory skin disease, characterised in most cases by sharply demarcated, erythematous, pruritic plaques covered…
4
Mins
28 Feb 2020
Long-Term Safety of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis through 3 Years (148 Weeks) from reSURFACE 1 and reSURFACE 2 Phase III Trials
IL-23 plays a key regulatory role in the pathogenesis of plaque psoriasis and medications targeting IL-23 have been shown to be effective for people with…
10
Mins
10 Jan 2020
Treat Psoriasis: A New Era is Coming
Development of psoriasis occurs due to interactions with epidermal keratinocytes and immune-system cells including T-lymphocytes, antigen-presenting…
8
Mins
10 Jan 2020
New Insights into Dimethyl Fumarate, an Oral Therapy for the Treatment of Plaque Psoriasis
Psoriasis is associated with high morbidity, causing problems in daily life such as itching and scaling, even for patients with less-severe disease…
4
Mins
19 Dec 2019
Connecting the Dots Between Skin and Allergy
Allergies represent a significant, rising health concern. Recent figures indicate that 150 million Europeans experience chronic allergic disease…
6
Mins
12 Dec 2019
IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance
The symposium “IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance” took place during the 2019 annual European Academy of Dermatology…
10
Mins
12 Dec 2019
Latest Highlights from Guselkumab in Psoriasis from EADV 2019
Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.
10
Mins
12 Dec 2019
Management of Moderate-to-Severe Atopic Dermatitis in the Era of Targeted Treatments
Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…
9
Mins
26 Nov 2019
Psoriasis and Atopic Dermatitis: Addressing Therapeutic Paradigms by Learning from Each Other
Psoriasis and AD are chronic, systemic inflammatory diseases of the skin characterised by upregulation of proinflammatory cytokines…
9
Mins
26 Nov 2019
Editor's Pick: Acne Therapy Across Time in the USA
Acne is the most common skin condition in the USA, affecting over half of its population.1 It is an inflammatory skin disease that predominantly…
10
Mins
26 Nov 2019
Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review
Atopic dermatitis (AD) is one of the most common and debilitating chronic inflammatory skin diseases, often greatly affecting physical, economical…
9
Mins
26 Nov 2019
Considering Tomorrow in Today’s Treatment Choice of Women Living with Psoriasis
The objectives of this symposium were to understand the importance of planning treatment addressing the specific needs of women living…
9
Mins
26 Nov 2019
Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases
Type 2 immunity evolved from a dialogue between the immune system and microbes. This form of immunity confers protection against bacteria, viruses…
3
Mins
26 Nov 2019
Near Circumferential Invasive Proliferative Gelatinous Mass in the Calf: An Unusual Presentation of Hidradenitis Suppurativa
Hidradenitis suppurativa, or acne inversa, is a chronic, recurrent inflammatory disease of the skin and subcutaneous tissue characterised by painful…
6
Mins
26 Nov 2019
Serum Sickness-Like Reaction in Children: Review of the Literature
The main objective of this manuscript is to offer an organised and updated review of the clinical features and current treatment options for paediatric serum sickness-like reaction.
7
Mins
26 Nov 2019
Rosacea: The Patient Experience is Now 'CLEAR'
Prof Schaller posed the question “what makes rosacea so special?” and explained that the manifestations of rosacea are very varied, including papules…
11
Mins
26 Nov 2019
IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability
Psoriasis is a common, chronic, immune-mediated skin disease affecting approximately 2–3% of the global population…
5
Mins
28 Oct 2019
Pathways to Silencing Psoriasis: Remission or Cure?
Psoriasis occurs more frequently alongside other IMID, indicating common pathogenetic pathways. Many of these IMID show familial accumulation…
4
Mins
18 Oct 2019
Advances and Latest Insights in Non-Biologic Systemic Therapeutic Agents in Psoriasis and Atopic Dermatitis
The fumarates, monoethyl fumarate (MEF) and dimethyl fumarate (DMF), are potent ester derivatives of fumaric acid. Fumaric acid esters (FAE)…
10
Mins
17 Sep 2019
IL-23 Inhibition in Psoriasis: A Novel Approach to Convenient, Consistent Clearance
This sponsored symposium took place on 12th June 2019 in Milan, Italy, as part of the 24th World Congress of Dermatology (WCD), 2019
9
Mins
16 Sep 2019
Spotlight on Acne
This symposium took place on 13th June 2019, as part of the World Congress of Dermatology (WCD) symposium in Milan, Italy
4
Mins
12 Sep 2019
Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review
Sarcoidosis is a multisystem disease, of unknown aetiology, which can involve any organ of the body, even if it more frequently affects the lymph nodes…
9
Mins
11 Sep 2019
IL-23 Inhibition as a Key Component in Psoriasis Treatment is Here to Stay
Prof Elke de Jong focussed her presentation on data from randomised clinical trials (RCT) and real-world evidence (RWE) from psoriasis patient registries.
10
Mins
20 Aug 2019
Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference
Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…
10
Mins
13 Jun 2019
Chemokine Pathway Can Be the Potential Therapeutic Target for Hypertrophic Scar
Hypertrophic scar (HTS) is a dermal form of fibroproliferative disease that develops after deep burns, skin injuries, and surgical wounds. HTS is defined…
10
Mins
13 Jun 2019
After Conventional Wisdom Has Failed, What Drives Wound Healing?
The purpose of this paper is to explore heat shock protein 90-alpha (Hsp90α)’s role as a potential driver of wound healing and as a possible future…
10
Mins
14 Mar 2019
Discover the Potential: Exploring New Frontiers of IL-23 Inhibitors
Affecting up to 11.4% of the population worldwide, psoriasis is one of the most common chronic autoinflammatory diseases.
9
Mins
14 Mar 2019
Clinical Conditions that Masquerade as Urticaria
Chronic urticaria is one of the most commonly diagnosed dermatoses. Following diagnosis, correct identification and proper treatment significantly reduces disease activity, thereby improving the patient’s quality of life.
10
Mins
12 Feb 2019
Translating Evidence to Practice: From Clinical Research to Real-World Experience
The goal of this programme is to support dermatologists to improve the management of patients with moderate-to-severe AD and bring together clinicians…
5
Mins
7 Feb 2019
Dimethyl Fumarate in Psoriasis Therapy
This presentation by Dr Weisenseel considered the role of fumaric acid esters (FAE) in plaque psoriasis.
9
Mins
29 Jan 2019
Unlocking the Potential of Immuno-Oncology in Advanced Cutaneous Squamous Cell Carcinoma: Role of Checkpoint Blockade
The rising incidence of CSCC presents a major challenge for healthcare systems and the frequency and impact of progression to advanced disease is…
8
Mins
13 Dec 2018
Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment
Following a brief introduction by Prof Lambert, the symposium started with an in-depth review of the current unmet needs in the clinical management of…
9
Mins
13 Dec 2018
Chronic Spontaneous Urticaria in Patients with Common Variable Immunodeficiency
Common variable immunodeficiency (CVID) is a predominantly antibody deficiency and is one of the most common primary…
10
Mins
30 Oct 2018
PASI 90/100, DLQI 0/1, and IL-17 Receptor/Cytokine: Does it Make a Difference and Are We Ambitious Enough?
The main objectives of the symposium were to review recent evidence on what difference targeting Psoriasis Area Severity Index (PASI) 90 or 100 and…
9
Mins
30 Oct 2018
Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey
The importance of discussions around the management of women of childbearing age with psoriasis, an issue that has been largely neglected for many years…
10
Mins
30 Oct 2018
Is Complete Skin Clearance in Psoriasis the Answer?
Prof Reich outlined the new understanding of psoriasis pathogenesis, with IL-23 rather than IL-12 considered the pivotal cytokine pathway. This…
9
Mins
30 Oct 2018
IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future
This symposium took place at the 27th European Academy of Dermatology and Venereology (EADV) Congress. The session examined the latest data for…
9
Mins
30 Oct 2018
From Evolution to Revolution: IL-23 in the Treatment of Psoriasis Patients
This symposium, which took place during the 2018 meeting of the European Academy of Dermatology and Venereology (EADV) in Paris, France, provided…
10
Mins
30 Oct 2018
Emerging Insights in the Treatment of Psoriasis and Psoriatic Arthritis
Guselkumab is a monoclonal antibody targeting IL-23 that is approved for the treatment of patients with moderate-to-severe plaque psoriasis. Two of…
9
Mins
30 Oct 2018
Efficacy, Sustainability, and Patient-Reported Outcomes of Guselkumab to Treat Plaque Psoriasis in the Post-Approval Setting
Plaque psoriasis is an autoimmune condition characterised by the development of red, dry, scaly skin lesions that cause irritation and pain for patients…
10
Mins
30 Oct 2018
Editor’s Pick: Beneath the Skin: The Relationship Between Psychological Distress and the Immune System in Patients with Psoriasis
Psoriasis is a chronic autoimmune skin disease with significant physical and psychiatric comorbidities and affects 2–3% of people worldwide.
5
Mins
30 Oct 2018
A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis
The objective of this study was to conduct a systematic review of the available evidence on the treatment of herpes simplex labialis with U.S. Food and Drug Administration (FDA)-approved topical antibiotics.
8
Mins
30 Oct 2018
Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
Chronic urticaria (CU) is characterised by intense recurrent itch, wheals, and/or angioedema, persisting for >6 weeks. CU can be subdivided into chronic…
10
Mins
30 Oct 2018
Lingual Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Successfully Treated with Adalimumab: A Rare Case Report and Review of Oral Psoriasis
Psoriasis is a common skin disease with various cutaneous manifestations and is classified into two clinical groups: non-pustular and pustular.
8
Mins
9 Aug 2018
The Changing Landscape of Psoriasis: New Horizons for Oral Therapies
Prof Boehncke opened the symposium and highlighted the changing landscape of psoriasis management. On behalf of Prof Mrowietz, who was unable to attend…
6
Mins
9 Aug 2018
Psoriasis: From Gene to Clinic
Substantial developments over the last decade have advanced our knowledge and understanding of psoriasis, from both a basic scientific and clinical…
10
Mins
21 Jun 2018
A Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018
This article reviews new data presented at the recent European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018. The role of topical…
Loading posts...
« Previous
1
…
19
20
21
22
23
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View